Alterations in NMDA Receptors in a Rat Model of Cortical Dysplasia

Journal of Neurophysiology - Tập 83 Số 1 - Trang 315-321 - 2000
R. Anthony DeFazio1, John J. Hablitz1
1Department of Neurobiology, University of Alabama at Birmingham, Birmingham, Alabama 35294

Tóm tắt

Recent studies have demonstrated an important role for the N-methyl-d-aspartate receptor (NMDAR) in epilepsy. NMDARs have also been shown to play a critical role in hyperexcitability associated with several animal models of human epilepsy. Using whole-cell voltage clamp recordings in brain slices, we studied evoked paroxysmal discharges in the freeze-lesion model of neocortical microgyria. The voltage dependence of epileptiform discharges indicated that these paroxysmal events were produced by a complex pattern of excitatory and inhibitory inputs. We examined the effect of the NMDAR antagonist d-2-amino-5-phosphopentanoic acid (APV) and the NMDA receptor subunit type 2B (NR2B)-selective antagonist ifenprodil on the threshold, peak amplitude, and area of evoked epileptiform discharges in brain slices from lesioned animals. Both compounds consistently raised the threshold for evoking the discharge but had modest effects on the discharge peak and amplitude. For comparison with nonlesioned cortex, we examined the effects of ifenprodil on the epileptiform discharge evoked in the presence of 2 μM bicuculline (partial disinhibition). In slices from nonlesioned cortex, 10 μM ifenprodil had little effect on the threshold whereas 71% of the recordings in bicuculline-treated lesioned cortex showed a >25% increase in threshold. These results suggest that NR2B-containing receptors are functionally enhanced in freeze-lesioned cortex and may contribute to the abnormal hyperexcitability observed in this model of neocortical microgyria.

Từ khóa


Tài liệu tham khảo

10.1016/S0169-328X(96)00162-3

10.1016/0920-1211(95)00045-3

10.1152/jn.1989.61.4.747

10.1152/jn.1999.81.1.404

DeFazio T., 1998, Epilepsia, 39, 7, 10.1111/j.1528-1157.1998.tb05142.x

10.1007/BF00688066

10.1007/BF00691477

10.1523/JNEUROSCI.17-07-02469.1997

10.1016/S0920-1211(98)00041-2

Hablitz J. J., 1992, Epilepsy Res., 8, 139

10.1016/0306-4522(94)90226-7

10.1093/cercor/6.3.514

10.1152/jn.1999.81.1.159

10.1523/JNEUROSCI.18-06-01935.1998

10.1016/0920-1211(90)90082-7

10.1152/jn.1998.80.1.92

10.1016/S0920-1211(96)00041-1

10.1016/0304-3940(90)90709-I

10.1016/S0920-1211(98)00048-5

10.1038/326701a0

10.1016/S0079-6123(08)60437-9

10.1523/JNEUROSCI.17-03-00983.1997

10.1111/j.1528-1157.1994.tb05989.x

10.1139/y97-036

10.1016/S0306-4522(97)00656-8

10.1139/y82-122

10.1152/jn.1999.81.5.2587

10.1016/S0920-1211(98)00040-0

10.1152/jn.1987.57.6.1911

10.1016/0006-8993(80)90119-5

10.1038/368144a0

10.1111/j.1469-7793.1998.013bu.x

10.1152/jn.1989.61.3.621

Williams K., 1993, Mol. Pharmacol., 44, 851

10.1097/00005072-199801000-00007

Thông tin
Thông tin xuất bản

Journal of Neurophysiology

Tập 83 Số 1

315-321

Thông tin tác giả